Despite a modest rise in quarterly revenue, Vancouver-based Response Biomedical Corp. (TSX:RBM) posted a 65% increase in its net loss for the six-month period ending June 30, 2007. Net loss for the diagnostic equipment developer rose to $6.
Read more >